Reproducibility of Cirrus Optical Coherence Tomography Measurements

This study has been completed.
Sponsor:
Information provided by:
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery
ClinicalTrials.gov Identifier:
NCT00643422
First received: March 22, 2008
Last updated: July 21, 2008
Last verified: July 2008
  Purpose

In this study the reproducibility of optical coherence tomography measurements should be evaluated.


Condition Intervention
Healthy
Device: Cirrus™ HD-OCT, Carl Zeiss Meditec AG

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Reproducibility of Retinal Thickness and Volume Measurements Determined With the Cirrus Spectral Domain OCT

Further study details as provided by The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery:

Primary Outcome Measures:
  • retinal thickness [ Time Frame: two ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • retinal volume [ Time Frame: two ] [ Designated as safety issue: No ]

Estimated Enrollment: 16
Groups/Cohorts Assigned Interventions
Observation Device: Cirrus™ HD-OCT, Carl Zeiss Meditec AG
the retinal thickness and volume is determined on two different days with the Cirrus™ HD-OCT.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

attendants of health care center

Criteria

Inclusion Criteria:

  • 18 years of age or older
  • best corrected visual acuity of at least 20/25
  • clear optical media

Exclusion Criteria:

  • any kind of retinal pathology
  • any kind of opacity of optical media
  • any kind of intraocular surgery
  • spherical refraction of more than 5 diopters
  • cylindrical refraction of more than 3 diopters
  • amblyopia
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00643422

Locations
Austria
Rudolf Foundation Clinic
Vienna, Austria, 1030
Sponsors and Collaborators
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery
  More Information

Publications:

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Stefan Hagen, MD, Ludwig Boltzmann Institute of retinology and biomicroscopic laser surgery
ClinicalTrials.gov Identifier: NCT00643422     History of Changes
Other Study ID Numbers: Cirrus_OCT_0308
Study First Received: March 22, 2008
Last Updated: July 21, 2008
Health Authority: Austria: Ethikkommission

Keywords provided by The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery:
normal eyes

ClinicalTrials.gov processed this record on April 17, 2014